Origins of Cystic Fibrosis Airway Disease
Origins of Cystic Fibrosis Airway Disease
批准号:
10226930
负责人:
DAVID A STOLTZ
金额:
$229.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-05 至 2023-06-30
关键词:
ATP12A geneAddressAffectAirway DiseaseAnimal ModelAnionsBacteriaBicarbonatesBirthCystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorDefectDevelopmentDiseaseDisease ProgressionDuct (organ) structureExhibitsFamily suidaeGenetic DiseasesGlandGoalsH(+)-K(+)-Exchanging ATPaseHost DefenseHourHumanImpairmentInfectionInflammationInfrastructureInvestigationKnowledgeLeadLearningLifeLinkLiquid substanceLungLung diseasesMediatingMethodsMorbidity - disease rateMucociliary ClearanceMucous body substanceNewborn InfantPathogenesisPlayPropertyProton PumpProton-Translocating ATPasesProtonsPulmonary Cystic FibrosisRegulator GenesResearchResearch PersonnelRespiratory FailureRoleSerumServicesSiteSurfaceTechniquesVirus Diseasesairway epitheliumairway obstructionairway surface liquidantimicrobialcystic fibrosis airwaydefined contributiondisease phenotypeearly cystic fibrosisgene discoveryinjured airwayinnovationinsightmortalitynovel therapeutic interventionnovel therapeuticsporcine modelpreventprogramsrecurrent infectionrespiratorysuccessvacuolar H+-ATPase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Twenty-eight years after the discovery of the CFTR gene, the causes of cystic fibrosis (CF) airway
disease remain controversial, we still lack answers to many critical questions, our therapies are
inadequate, and CF remains a life limiting and too often lethal disease. A major impediment to progress
has been lack of CF animal models with a lung disease phenotype resembling humans with CF. We
developed pigs with targeted alterations of the CFTR gene. CF pigs spontaneously develop the hallmark
features of CF lung disease, including airway infection, inflammation, airway wall remodeling, mucus
accumulation, and airway obstruction. Within hours of birth, CF pigs fail to eradicate bacteria as
effectively as wild-type pigs. At least two host defense defects, reduced antimicrobial activity in airway
surface liquid (ASL) and impaired mucociliary transport (MCT) contribute. Both were caused by
abnormally acidic airway liquid. In this Program three highly accomplished investigators will use CF pigs
to answer fundamental questions about CF lung disease. Together, the three projects will discover how
loss of CFTR function affects: a) submucosal gland function, the properties of mucus, and MCT; b) ASL
pH and proton secretion via ATP12A; and, c) small airways function, a likely site of CF disease
pathogenesis. The Project Leaders and their teams have an outstanding track record of collaborative CF
research, and here they sharpen their focus to a common goal. Their highly creative research is
supported by five cores that provide innovative infrastructure and services. By further educating CF
pathogenesis, it will accelerate discovery of novel therapies for this lethal disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Climate Change and Lung Health Training Program
-
批准号:10556149
-
项目类别:
-
资助金额:$28.85万
-
财政年份:2023
-
负责人:DAVID A STOLTZ
-
依托单位:
Testing the Contributions of Airway Submucosal Glands and Surface Epithelia to Lung Health
-
批准号:10597111
-
项目类别:
-
资助金额:$62.95万
-
财政年份:2022
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10677590
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10024664
-
项目类别:
-
资助金额:$61.06万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10248526
-
项目类别:
-
资助金额:$60.83万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Animal Models Core
-
批准号:10470334
-
项目类别:
-
资助金额:$59.97万
-
财政年份:2020
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
-
批准号:10155587
-
项目类别:
-
资助金额:$105.36万
-
财政年份:2017
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
-
批准号:9289053
-
项目类别:
-
资助金额:$107.03万
-
财政年份:2017
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Alkalinization and Repurposing Tromethamine as a Therapeutic Approach in Cystic Fibrosis
-
批准号:9918957
-
项目类别:
-
资助金额:$105.46万
-
财政年份:2017
-
负责人:DAVID A STOLTZ
-
依托单位:
Airway Goblet Cells: Friend or Foe?
-
批准号:8355114
-
项目类别:
-
资助金额:$226.5万
-
财政年份:2012
-
负责人:DAVID A STOLTZ
-
依托单位:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
-
批准号:8110743
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2010
-
负责人:DAVID A STOLTZ
-
依托单位:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
-
批准号:7919812
-
项目类别:
-
资助金额:$5.0万
-
财政年份:2009
-
负责人:DAVID A STOLTZ
-
依托单位:
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease
-
批准号:10470210
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Core A: Animals Models-Stoltz
-
批准号:10470206
-
项目类别:
-
资助金额:$71.22万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Origins of Cystic Fibrosis Airway Disease
-
批准号:10470203
-
项目类别:
-
资助金额:$229.33万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Porcine PPG Administration Core
-
批准号:10470205
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Core A: Animals Models-Stoltz
-
批准号:10226932
-
项目类别:
-
资助金额:$71.27万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Porcine PPG Administration Core
-
批准号:10226931
-
项目类别:
-
资助金额:$6.23万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Project 1: Mucociliary Transport in Cystic Fibrosis Lung Disease
-
批准号:10226937
-
项目类别:
-
资助金额:$37.18万
-
财政年份:2008
-
负责人:DAVID A STOLTZ
-
依托单位:
Paraoxonase-2 S311C Polymorphism Alters Glycosylation and Lactonase Activity
-
批准号:7994211
-
项目类别:
-
资助金额:$12.63万
-
财政年份:2007
-
负责人:DAVID A STOLTZ
-
依托单位:
海外基金